Colossal unveils GenoMorph AI and names about 2,300 candidate dodo beak gene targets
Colossal Biosciences announced GenoMorph, an AI platform that flagged roughly 2,300 candidate regulatory DNA elements linked to dodo beak size, thickness and breadth. The company said it built an avian regulatory atlas from chicken, quail, duck and pigeon embryonic samples and that the elements are entering laboratory validation studies.
AI-assisted synthesis · Based on 5 outlets' reporting · Full text read from 2 of 5 outletsHow it's made
What happened
Key facts
- Colossal Biosciences announced GenoMorph, an AI platform to identify candidate gene-editing targets for de-extinction projects (per newscord.org, TechCrunch).
- Colossal said GenoMorph identified approximately 2,300 candidate regulatory DNA elements linked to dodo craniofacial morphology (per newscord.org, TechCrunch).
- Colossal said the candidate elements include more than 650 linked to beak size and almost 1,700 linked to beak thickness and breadth (per newscord.org).
- Colossal said it constructed an avian regulatory atlas using hundreds of embryonic samples from chickens, quail, ducks and pigeons across six developmental stages and three facial regions (per newscord.org, TechCrunch).
- Colossal announced GenoMorph on October 14, 2026 (per TechCrunch).
- Ben Lamm, Colossal’s co-founder and CEO, said de-extinction is as much a data problem as a biology problem and described GenoMorph’s predictive approach (per newscord.org, TechCrunch).
- Beth Shapiro, Colossal’s chief science officer, said the dodo’s anatomy emerged from networks of regulatory instructions and that a comparative approach was necessary (per newscord.org, TechCrunch).
- Colossal said the candidate regulatory elements are entering validation studies (per newscord.org, TechCrunch, dallasinnovates.com).
- Colossal said its Nicobar pigeon colony in Texas has 36 birds and that the company has created cells that can become eggs and sperm (per newscord.org, TechCrunch).
The brief
Colossal Biosciences unveiled GenoMorph, an artificial-intelligence platform the company says can predict regulatory DNA elements that shape bird craniofacial form and that has produced roughly 2,300 candidate targets relevant to the extinct dodo’s beak.
The company described GenoMorph as combining comparative genomics, developmental biology and high-resolution 3D morphology to infer which DNA regions are active during avian development and hence likely to act as genetic switches for size, thickness and breadth of the beak.
Colossal said it built an avian regulatory atlas from hundreds of embryonic samples drawn from chickens, quail, ducks and pigeons at six developmental stages while tracking three facial areas, and that the atlas underpins GenoMorph’s predictions.
Ben Lamm, Colossal’s co-founder and CEO, framed the effort as solving a data challenge as well as a biological one, and Beth Shapiro, the company’s chief science officer, described the dodo’s form as emerging from ‘‘networks of regulatory instructions,’’ arguing that comparative developmental data were necessary because Colossal has only a single dodo genome.
Colossal reported that among the candidate elements GenoMorph nominated are more than 650 associated with beak size and nearly 1,700 associated with beak thickness and breadth, and the company said those elements are entering laboratory validation studies to test their effects.
The company also said it is progressing other parts of its dodo pipeline: it reported that its Nicobar pigeon colony in Texas now numbers 36 birds and that it has produced germline precursor cells the company described as the essential cells that become eggs and sperm.
TechCrunch’s account dated the announcement to October 14, 2026, while Colossal’s statements in company materials emphasize the comparative-data approach and the gap between the volume of genomes available for birds and for projects such as the woolly mammoth, where Colossal said it has about 100 genomes.
Colossal said its dodo genome is now filled to 95% and did not announce a timeline for hatching a dodo; the company said GenoMorph’s outputs will move into experimental validation rather than claiming immediate organismal reconstruction.
Across the two reports, Colossal presented GenoMorph as a platform intended for use beyond the dodo project, to accelerate identification of candidate editing targets in cases where comparative genomic data are sparse and developmental morphology matters for phenotype reconstruction.
Why it matters
- Scientists and conservation practitioners working on de-extinction projects face a data shortfall for tropical, poorly preserved genomes; Colossal’s GenoMorph aims to convert comparative embryonic and morphological datasets into testable genetic targets, shifting costs toward laboratory validation of hundreds to thousands of candidate elements rather than broad, unguided experimentation.
- For Colossal’s dodo effort, the company reports roughly 2,300 candidate regulatory elements and a dodo genome filled to 95%; the concrete stakes are the laboratory resources required to validate hundreds of candidate edits and the maintenance of a 36-bird Nicobar pigeon colony that supplies comparative biological material.
- Genomic-resource disparities documented by Colossal—about 1 dodo genome versus roughly 100 mammoth genomes for a separate project—create differing technical challenges and incentives for platform development and fundraising, with the company positioning GenoMorph to reduce reliance on large numbers of preserved genomes.
What to watch next
- Whether Colossal publishes peer-reviewed validation results showing functional effects for any of the approximately 2,300 candidate regulatory elements.
- Whether Colossal reports experimental outcomes from the validation studies it said the candidate elements are entering, including which specific elements (size-linked or thickness/breadth-linked) produce measurable craniofacial changes.
- Whether Colossal advances from filled dodo genome status—reported at 95% by the company—to a fully closed genome sequence and publishes the assembly and annotation details.
- Whether Colossal expands or documents changes to its Nicobar pigeon colony beyond the 36 birds the company reported.
How it's being covered
Coverage analysisShow details6 source articles · 5 unique outletsCoverage mix: Center Only· 3 CenterWhere the outlets are based: US/Canada 60% · Unknown 40%
- Coverage is currently concentrated among Center-rated outlets (3 of 3 rated sources); comparatively few Left or Right-rated outlets have published on the event.
How outlets' accounts compare
1 factual disagreement · 2 framing differences · 3 uncorroborated claims · 4 information gaps- The exact phrasing of the candidate-element counts differs in emphasis: newscord.org separates the totals into more than 650 for beak size and almost 1,700 for thickness and breadth, while TechCrunch reports a rounded total of approximately 2,300 promising targets without repeating the same breakdown.
- newscord.org emphasizes the breakdown of candidate elements into counts for beak size and beak thickness/breadth and highlights the construction of an avian regulatory atlas; TechCrunch frames GenoMorph primarily as a solution for projects with limited genomes and contrasts data availability between the dodo and woolly mammoth projects.
- newscord.org gives a breakdown: more than 650 elements for beak size and almost 1,700 for thickness/breadth; TechCrunch gives a single rounded figure of approximately 2,300 candidate targets.
- Both newscord.org and TechCrunch attribute the GenoMorph announcement and the candidate counts to Colossal Biosciences and to statements by Ben Lamm; newscord.org additionally attributes explanatory comments to Beth Shapiro.
- Ben Lamm said, "De-extinction is as much a data problem as a biology problem."
- Beth Shapiro said the dodo’s anatomy emerged from "networks of regulatory instructions."
- Both sources present GenoMorph’s predictions as derived from comparative embryonic and morphological data; neither source documents causal confirmation from laboratory experiments, so causal claims remain unverified.
- No report Updat3 read reported independent peer-reviewed validation data verifying that any GenoMorph-predicted element causally alters beak morphology.
- No source provided independent external expert assessment or replication attempts outside Colossal’s statements.
- No source discussed regulatory, ethical, or permitting steps required for genetic editing experiments tied to de-extinction in the jurisdictions where Colossal operates.
How we got here
Immediate backdrop: Colossal Biosciences was founded in 2021 by Ben Lamm and George Church, who in public statements that year framed the company’s mission around de‑extinction and large‑scale genomic engineering.
Structural roots: the widespread use of CRISPR‑Cas9 for programmable genome editing traces to landmark demonstrations in 2012 (Jinek et al.) and the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier and Jennifer Doudna, which normalized CRISPR as a research tool.
Original sources
6 articles from 5 outletsEvery story links to the reporting it was built from. How we choose sources
Spotted a factual error, a broken link or a misleading summary? Tell us.